Related Experiment Video
Updated: Apr 22, 2026

09:00
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
Published on: April 18, 2025
1.4K
MS/MS-based strategies for proteomic profiling of invasive cell structures
1Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada.
Proteomics
|October 11, 2014
Summary
Cancer cells invade tissues using specialized structures like pseudopodia and extracellular vesicles. Understanding their protein composition is key to developing anti-metastatic therapies.
Area of Science:
- Cell Biology
- Cancer Research
- Proteomics
Background:
- Cancer cell invasion of the extracellular matrix drives metastatic spread, the primary cause of cancer mortality.
- Invasive phenotypes are mediated by specialized cellular structures including pseudopodia, invadopodia, podosomes, and extracellular vesicles.
- Identifying molecular targets within these structures is crucial for developing anti-metastatic therapies.
Purpose of the Study:
- To review the current understanding of the protein composition and interaction networks of cancer cell invasive structures.
- To highlight the role of extracellular vesicles as mediators of invasive cell phenotypes.
- To outline challenges and future perspectives in the proteomic characterization of these structures.
Main Methods:
- Mass spectrometry-based protein identification (MS/MS) is employed for proteomic profiling.
- Analysis of protein composition and topology of interaction networks.
- Review of existing literature on pseudopodia, invadopodia, podosomes, and extracellular vesicles.
Main Results:
- Progress in characterizing the protein makeup of pseudopodia, invadopodia, podosomes, and extracellular vesicles is summarized.
- Extracellular vesicles are increasingly recognized as significant mediators of invasive cell phenotypes.
- The proteomic landscape of these invasive structures is complex and multifaceted.
Conclusions:
- Understanding the molecular mechanisms of cancer cell invasion structures is vital for anti-metastatic drug development.
- Proteomic approaches, particularly MS/MS, are powerful tools for dissecting these complex cellular components.
- Further research into the protein networks of these structures holds promise for novel therapeutic strategies.

